Table 2.
Cont.-BMI <25 | PCOS-BMI <25 | p | Cont.-BMI >25 | PCOS-BMI >25 | p | |
---|---|---|---|---|---|---|
Neopterin (nmol/L) | 10.3±9.2 | 15±10 | 0.191 | 11.0±10.1 | 11.2±11.5 | 0.772 |
IL-6 (ng/L) | 172.5±140 | 232±148.1 | 0.269 | 159±100 | 115±101 | 0.241 |
TNF-α (ng/L) | 294±292.2 | 313±248 | 0.901 | 214.5±233 | 212±242.1 | 0.772 |
CRP (mg/dl) | 1.0±2.0 | 0.5±0.5 | 0.633 | 0.3±0.3 | 1.5±1.3 | 0.007 |
NLR | 4.5±8.3 | 10.3±11.0 | 0.120 | 2.2±1.0 | 7.3±8 | 0.152 |
B12 (pg/ml) | 258.3±94.4 | 257±194.5 | 0.407 | 271±106 | 256±219 | 0.206 |
Total-C (mg/dl) | 140.4±26 | 196.5±54.3 | 0.001 | 200.2±45 | 187.1±49.2 | 0.395 |
TAG (mg/dl) | 76.0±18.3 | 116±41.3 | 0.007 | 155±100.1 | 156±59 | 0.309 |
Fasting B.G (mg/dl) | 92.1±16.4 | 101±19.5 | 0.177 | 91±12.5 | 107.1±16 | 0.001 |
E2 (pg/ml) | 69±58.3 | 157.1±186 | 0.178 | 46.4±17 | 90±83.1 | 0.221 |
FG Score | 6.0±1.0 | 11.3±3.3 | 0.000 | 7.3±0.6 | 12.0±3.1 | 0.000 |
F.test. (uıU/ML) | 1.1±1 | 1.4±1 | 0.395 | 1±1 | 2±1.2 | 0.074 |
LH/FSH (muı/ml) | 1.3±1 | 2.3±1.3 | 0.024 | 1.3±1 | 2±1.5 | 0.065 |
WHR (cm) | 1±0.1 | 1±0.1 | 0.000 | 0.8±0.1 | 0.9±0.02 | 0.024 |
Age | 26± 3 | 24.4± 4 | 0.347 | 30 ±4.5 | 28±4 | 0.149 |
BMI | 20.4 ±2 | 20.3 ±2.2 | 0.763 | 27±1 | 27.3± 2 | 0.412 |
Data are presented as mean ± standard deviation. There are used student t test and nonparametric Mann-Whitney U test. p values: p values denoting the outcomes of comparison of the parameters of biochemical obese patients with PCOS and obese control, non-obese patients with PCOS and non-obese control groups. p<0.05 was considered to be statistically significant. CRP – C-reactive protein; TNF-α – tumor necrosis factor-α; IL-1 – interleukin-1; IL-6 – interleukin-6; NLR – neutrophil to lymphocyte ratio; TAG – triglyceride; Total-C – total cholesterol; FSH – follicle-stimulating hormone; LH – luteinizing hormone; E2 – Estradiol2; F.test – free testosterone; BMI – Body Mass Index; WHG – waist-to-hip ratio; FG score – Ferriman-Gallowey score; Fasting B.G. – fasting blood glucose.